SCHEMBL33527886

SCHEMBL33527886

COc1ccc2c(c1)Cc1cc(C(C)(C)C)ccc1-2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.50
CYP1A2 P05177 2/20 0.48
ALDH1A1 P00352 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
ALOX15 P16050 1/20 0.48
HSD17B10 Q99714 1/20 0.48
DRD2 P14416 4/20 0.47
DRD1 P21728 4/20 0.47
DRD5 P21918 4/20 0.47
DRD3 P35462 4/20 0.47
CYP19A1 P11511 4/20 0.43
DRD4 P21917 2/20 0.43
CYP11B2 P19099 2/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
MAOB P27338 1/20 0.42
BCL2 P10415 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4581239 0.85 METAP1 (0.63) METAP1CYP1A2ALDH1A1CYP3A4CYP2C9
SCHEMBL30777630 0.85 METAP1 (0.63) METAP1CYP1A2ALDH1A1CYP3A4CYP2C9
SCHEMBL29459210 0.85 ALDH1A1 (0.45) CYP1A2ALDH1A1ALOX15HSD17B10KDM4E
SCHEMBL40372 0.85 ALDH1A1 (0.45) CYP1A2ALDH1A1ALOX15HSD17B10KDM4E
SCHEMBL24517924 0.85 ALDH1A1 (0.39) METAP1CYP1A2ALDH1A1CYP3A4CYP2C9
SCHEMBL6552336 0.83 ALDH1A1 (0.44) CYP1A2ALDH1A1ALOX15HSD17B10KDM4E
Lithium SCHEMBL6552341 0.83 ALDH1A1 (0.44) CYP1A2ALDH1A1ALOX15HSD17B10KDM4E
Hydrochloric Acid SCHEMBL28338025 0.81 ALDH1A1 (0.42) CYP1A2ALDH1A1ALOX15HSD17B10KDM4E
SCHEMBL16017944 0.81 ADORA1 (0.46) ALDH1A1CYP3A4CYP11B2ADORA1KDM4E
SCHEMBL28338024 0.78 ALDH1A1 (0.40) CYP1A2ALDH1A1ALOX15HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260092028-A1 ONE-POT SYNTHESIS OF SUBSTITUTED FLOURENES CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092028-A1 ONE-POT SYNTHESIS OF SUBSTITUTED FLOURENES DYRK1B, DYRK2, DYRK4 METAP1 2580/4885CYP1A2 2623/4885ALDH1A1 2367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.